Mandell, Jeffrey D. http://orcid.org/0000-0002-3839-2543
Fisk, J. Nick http://orcid.org/0000-0002-1940-393X
Cyrenne, Ethan
Xu, Mina L. http://orcid.org/0000-0001-9513-245X
Cannataro, Vincent L. http://orcid.org/0000-0002-6364-7747
Townsend, Jeffrey P. http://orcid.org/0000-0002-9890-3907
Article History
Received: 27 May 2022
Revised: 26 October 2022
Accepted: 28 October 2022
First Online: 11 November 2022
Competing interests
: JPT has consulted for Black Diamond Therapeutics, Agios Pharmaceuticals, and Servier Pharmaceuticals. VLC has consulted for Black Diamond Therapeutics. MLX has consulted for Blueprint Medicines and Pure Marrow and has served on the advisory board for Seattle Genetics. Other authors declare no competing interests.